sam altman it seems that he is ready to move on and move on with a new project that apparently would have nothing to do with Open AI and the Artificial Intelligence of ChatGPT. Since its objective is more “human”: to make people live longer.
During the last months we have seen how the debate around this platform has exploded and the potential implications that it may have in the future, impacting the social, work and personal lives of thousands, if not millions of people.
In this vein, Sam Altman himself has spoken about the issue of what professions or jobs would survive the passage of Generative Artificial Intelligence systems such as ChatGPT. And the picture is not necessarily encouraging.
For the tycoon, the job that will survive the passage of Artificial Intelligence is that of teachers. Where AI systems will be a tool for his work in training his students.
The education industry would therefore be the least affected by AI, according to Altman, and teachers will continue to be valuable in the teaching and learning process, since he believes that human interactions will prefer to deal with other human beings.
And now he’s looking at a new project where he’s basically invested his current wealth.
Sam Altman wants you to be old for more years
an article of MIT Technology Review reveals that Sam Altman has launched two new projects, investing several million dollars in a couple of very ambitious projects that bear little relation to ChatGPT.
The outlet ensures that the OpenAI co-founder has revealed that he virtually emptied his bank account to finance a couple of companies that are pursuing two other goals that are very different from their AI but are equally ambitious: unlimited energy and long useful life.
One of those bets is on the fusion energy startup Helion Energyin which he invested more than US$375 milliona figure that has been corroborated by the CNBC in the year 2021. While the other company has turned out to be the most disturbing: Retro Biosciences, a project to which Altman handed checks totaling US$180 million same year:
“Its a lot of money. Basically, I took all of my liquid net worth and put it into these two companies.”
This is what Sam Altman pointed out, disclosing this investment that had not been previously reported. According to the firm’s own operating statutes, the objective of this company is to “find and demonstrate anti-aging mechanisms in non-human mammals and then translate those scientific strategies to humans.”
In other words, they want to find the key to making humans live longer. Is that worth an investment of USD $180 million? Sam Altman thinks so.